Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 6, 2002, Pages 1629-1633

  Liu, Mingfu ^a   Douthwaite, Stephen ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; CLARITHROMYCIN; ERYTHROMYCIN; GENE PRODUCT; HMR 3004; KETOLIDE; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PROTEIN ERM; RIBOSOME RNA; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DEMETHYLATION; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RNA METHYLATION; STRAIN DIFFERENCE; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; DEALKYLATION; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; KETOLIDES; MACROLIDES; METHYLATION; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PLASMIDS; RNA, BACTERIAL; RNA, RIBOSOMAL; TRANSCRIPTION FACTORS;

EID: 0036096197     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.6.1629-1633.2002     Document Type: Article

References (49)

1. The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution
2. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent
3. Ketolides: Telithromycin, an example of a new class of antibacterial agents
4. A T5 promoter based transcription-translation system for the analysis of proteins in vivo and in vitro
5. Cloning of a lincosamide-resistant determinant from Streptomyces caelestis, the producer of celesticetin, and characterization of the resistance mechanism
6. Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli
7. Recognition sites for antibiotics in rRNA
8. Monomethylating and dimethylating activities and kinetic studies of the ErmC 23S ribosomal RNA methyltransferase
9. Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA
10. The macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domains II of 23S rRNA
11. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents
12. The polypeptide tunnel system in the ribosome and its gating in erythromycin resistance mutants of L4 and L22
13. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA
14. 1G745-deficient mutant
15. Lessons from an evolving rRNA: 16S and 23S rRNA structures from a comparative perspective
16. New method for generating deletions and gene replacements in Escherichia coli
17. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status
18. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA
19. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species
20. 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase
21. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
22. The tylosin resistance gene tlrB of Streptomyces fradiae encodes a methyltransferase that targets G748 in 23S rRNA
23. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA
24. Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan
25. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
26. The macrolide-lincosamide-streptogramin B resistance phenotypes characterized by using a specifically deleted, antibiotic-sensitive strain of Streptomyces lividans
27. Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms
28. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin
29. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants
30. The RNA modification database: 1999 update
31. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria
32. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria
33. Mutants of Escherichia coli permeable to actinomycin
34. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli
35. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics
36. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America
37. Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase
38. Macrolide resistance conferred by base substitutions in 23S rRNA
39. Erythromycin resistance by ribosome modification
40. Macrolide resistance
41. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre
42. Methylation of 23S rRNA caused by tlrA (ermSF), a tylosin resistance determinant from Streptomyces fradiae
43. Cloning of tlrD, a fourth resistance gene, from the tylosin producer, Streptomyces fradiae
44. Induction of ribosomal methylation in MLS-resistant Streptococcuspneumoniae by macrolide and ketolides